Carbapenem-Resistant Gram-Negative Bacilli
Cross-source consensus on Carbapenem-Resistant Gram-Negative Bacilli from 1 sources and 4 claims.
1 sources · 4 claims
How it works
Risks & contraindications
Background
Where it comes from
Highlighted claims
- Carbapenem-resistant Gram-negative bacilli are a critical subset of multidrug-resistant organisms that create growing health and economic burdens worldwide. — Cost-effectiveness of infection prevention and control measures for carbapenem-resistant Gram-negative bacilli: A systematic review protocol
- CRGNB infections are associated with high morbidity, longer hospital stays, elevated mortality, and rising incidence and prevalence. — Cost-effectiveness of infection prevention and control measures for carbapenem-resistant Gram-negative bacilli: A systematic review protocol
- The 2008 detection of NDM-1 provides the rationale for beginning the review search window on 1 January 2009. — Cost-effectiveness of infection prevention and control measures for carbapenem-resistant Gram-negative bacilli: A systematic review protocol
- Carbapenem resistance can arise through carbapenemase enzyme production. — Cost-effectiveness of infection prevention and control measures for carbapenem-resistant Gram-negative bacilli: A systematic review protocol